Zobrazeno 1 - 6
of 6
pro vyhledávání: '"AB Aravind"'
Publikováno v:
In Biomedicine & Pharmacotherapy February 2019 110:29-36
Autor:
Girish Daginakkatte, Kavitha Nellore, Sunil Kumar Panigrahi, Sagar dadhania, AB Aravind, Thomas Antony, Megha Goyal, Murali Ramachandra, DS Samiulla, Prasath Kothandaraman, Susanta Samajdar, Dinesh Chikkanna, Rashmi Nair, Kishore Narayanan, Chandregowda Venkateshappa, Garima Priyadarshani, Vijay Kamal Ahuja
Publikováno v:
Cancer Research. 81:1713-1713
CD73 is a cell surface ectoenzyme, which is overexpressed in many types of human and mouse cancers. CD73 is the primary enzymatic producer of immunosuppressive adenosine in the tumor microenvironment, and high CD73 expression is associated with signi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6770a1481a560c322428f79e49bda279
https://doi.org/10.1158/1538-7445.am2021-1713
https://doi.org/10.1158/1538-7445.am2021-1713
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Avainash Kumar, Olli Törmäkangas, Susanta Samajdar, AB Aravind, Suraj Tgore, Subhendu Mukherjee, Nirbhay Kumar Tiwari, Girish Daginakatte, Anu Moilanen, Raghurami B Reddy, Laura Ravanti, Thomas Antony, Elina Mattila, Mari Björkman, Janith Mary Maben, Shekar Chelur, Mahaboobi Jaleel, Nvm Rao Bandaru, Akhila Srinivas, Indu Bansal, DS Samiulla, Rakesh P. Nankar, Kavitha Nellore, Chandrasekhar Abbineni, Chandranath D. Naik, Sanjeev Giri, Murali Ramachandra, Gerd Wohlfahrt, Naveen Kumar, Sivapriya Marappan
Publikováno v:
Cancer Research. 80:1754-1754
Background: Inhibition of Bromodomain and extra-terminal (BET) family proteins by small molecules is actively being pursued as a therapeutic strategy in the clinics. Targeted protein degradation is an emerging therapeutic modality that has shown init
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dac44ba72bb66c0059e6c8a84001aa4d
https://doi.org/10.1158/1538-7445.am2020-1754
https://doi.org/10.1158/1538-7445.am2020-1754
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 110, Iss, Pp 29-36 (2019)
Malignant melanoma continues to be a fatal disease for which novel and long-term curative breakthroughs are desired. One such innovative idea would be to assess combination therapeutic treatments – by way of combining two potentially effective and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e32c4087212eb5c339e6fa490981b7
https://pubmed.ncbi.nlm.nih.gov/30458345
https://pubmed.ncbi.nlm.nih.gov/30458345
Autor:
Sunil Kumar Panigrahi, Jiju Mani, AB Aravind, Thomas Anthony, Girish Daginakatte, Kishore Narayanan, Garima Priyadarshini, Susanta Samajdar, Kavitha Nellore, Sagar dadhania, Murali Ramachandra, Dinesh Chikkanna, DS Samiulla, Megha Goyal
Publikováno v:
Cancer Research. 79:4086-4086
As a potent immunosuppressor adenosine is essential for maintaining tissue homeostasis and preventing an overzealous immune response during inflammation and infection. However, adenosine generated within the tumor microenvironment by the action of ec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::805a83d5c37f608d80536416c2b7089d
https://doi.org/10.1158/1538-7445.am2019-4086
https://doi.org/10.1158/1538-7445.am2019-4086